PATENT CLAIM ANALYSIS

Application Number: 16037268
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "004800"]

Abstract:
The disclosure relates to therapeutic methods for regulating weight gain, metabolic syndrome, and insulin resistance. In certain embodiments, the disclosure relates to methods of treating or preventing obesity, metabolic syndrome, or insulin resistance by administering an effective amount of a pharmaceutical composition comprising one or more GDNF receptor agonists to a subject in need thereof.

Claim (Index 8):
The method of  claim 7 , wherein the subject is a human subject.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 95.0
- Lexical Diversity: 1.40909
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15003324', '14778379', '13157977', '15454662', '14214161']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7449404265900159
- 35 USC 102 Novelty (BERT): 0.5943919398667397
- Combined Prediction Score: 0.7298855779176883
- Mean Citation Score: 361.104952
- Max Citation Score: 572.8546
- Similarity Product: 391.2058274299264

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test